Abbott India Ltd share price logo

Abbott India Ltd (ABBOTINDIA)

₹27404.154.83%

bell
Get free price alerts. Set up your Free investment account to get Live Prices.
Overview
News
Financials
Q1 2024 Results
Technicals

Analyst Rating

based on 7 analysts

BUY

66.67%

Buy

0.00%

Hold

33.33%

Sell

Based on 7 analysts offering long term price targets for Abbott India Ltd. An average target of ₹27670.43

Source: S&P Global Market Intelligence

Abbott India Ltd Share analysis

Source: S&P Global Market Intelligence

Performance

  • Day's Low

    Day's High

    ₹27,221
    ₹28,400
  • 52 Week's Low

    52 Week's High

    ₹22,000
    ₹29,638.95
1 Month Return+ 1.85 %
3 Month Return+ 4.13 %
1 Year Return+ 15.8 %
Previous Close₹28,795.65
Open₹28,356.60
Volume16.89K
Upper Circuit-
Lower Circuit-
Market Cap₹61,190.76Cr

Key Statistics

P/E Ratio0
PEG Ratio0
Market Cap₹61,190.76 Cr
P/B Ratio15.48
EPS35.67

Mutual Fund Holdings

Funds HoldingsPrev. 6M
SBI Large & Midcap Fund Direct GrowthSBI Large & Midcap Fund Direct Growth2.37%
Canara Robeco Emerging Equities Direct Plan Growth OptionCanara Robeco Emerging Equities Direct Plan Growth Option1.91%
Axis Midcap Fund Direct Plan GrowthAxis Midcap Fund Direct Plan Growth1.51%
SBI Magnum Global Fund Direct GrowthSBI Magnum Global Fund Direct Growth5.37%
Nippon India Pharma Fund - Direct Plan - Growth PlanNippon India Pharma Fund - Direct Plan - Growth Plan3.22%

Company Information

Abbott India Ltd is a leading multinational pharmaceutical company in India, with its headquarters in Mumbai. It has manufacturing facilities in Goa and independent contract/third party manufacturers based across the country. The company provides products and solutions across therapeutic areas such as Womens Health, Gastroenterology, Central Nervous System, Metabolics, MultiSpecialty, Vaccines and Consumer Health. In 2002, they sold their Jejuri Undertakings with assets and liabilities as a going concern. In 2003, they amalgamated Knoll Pharmaceuticals Ltd with the company. In 2004, they started capsule production with a capacity of 27 million nos. and in 2005, they further increased the capacity to 56 million nos. and started a new project of producing nutritional products with installed capacity of 600 tonnes. In 2006, the production capacity of Tablets was also increased by 236 million nos to 686 million. In 2008, they launched Digene Total buffered pantoprazole tablet, Bruge, and Thyronorm 150 Digene along with Sugar Free Tablet and Gel. In 2018, Abbott India Ltd formed a new Business Unit GI Advance which followed a Build Operate Transfer model. During the year 2020-21, the company made an innovation in Brufen Coating formula leading to 50% increase in coating installed capacity. It further executed 8 new studies and published 8 articles in major indexed journals. Abbott India also launched 10 new products in various therapy segments leading to their recognition as The Most Innovative MNC of the Year 2019 at the 12th Pharma Leaders Award. The Drug Price Control Order 2013 brought several products of Abbott India under price control, leading to an adverse impact on sales and profits. They also received approvals to conduct phase 3 studies in adults/eldery and pediatric for their Influvac Quadrivalent Vaccine QIV Program. Abbott India has been making continuous efforts for portfolio expansion launching unique products and leveraging technology for better healthcare outcomes.

Share Price: ₹27404.15 per share as on 19 Jul, 2024 04:01 PM
Market Capitalisation: ₹61,190.76Cr as of today
Listing date: 03 Nov, 1994
Chairperson Name: Munir Shaikh
OrganisationAbbott India Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Abbott India Ltd

  • Abbott India Ltd to Go Ex-Dividend Soon - 14 Jul, 2024

    Abbott India Ltd is set to go ex-dividend in the next four days, with a dividend payment of ₹410.00 per share. The company has a trailing yield of 1.5% on its current stock price of ₹27472.70. Abbott India's growing earnings per share and conservative payout ratios make it an attractive investment opportunity.

  • Abbott India to Increase Dividend Payment - 13 Jul, 2024

    Abbott India Limited has announced an increased dividend payment of ₹410.00, with a yield of 1.5%. The company has a history of stable dividends and is expected to see a rise in earnings per share by 34% over the next year. The payout ratio is estimated to be sustainable at 68%, leaving cash for reinvestment into the business.

Insights on Abbott India Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 7.26% to 7.57% in Mar 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Zydus Lifesciences Ltd has given 85.3% return, outperforming this stock by 69.5%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 74.99% of holdings in Mar 2024 quarter

  • imgNO EFFECT

    FII Holding Unchanged

    img

    Foreign Institutions holdings remained unchanged at 0.18% of holdings in Mar 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 131.9% return, outperforming this stock by 75.0%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 16.10% to 15.93% in Mar 2024 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, ABBOTINDIA stock has moved down by -4.2%

Company Financials

Value in ₹ crore
2024Y/Y Change
Total Assets
₹5,201.54Cr
↑13.98%
Total Liabilities
₹1,502.65Cr
↑9.27%
Value in ₹ crore
2024Y/Y Change
Operating Cash Flow
₹1,212.81Cr
↑35.75%

Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
74.99%
0.00
Foreign Institutions
0.18%
0.00
Mutual Funds
7.57%
0.00
Retail Investors
15.93%
0.00
Others
1.34%
0.00

Key Indicators

Earnings and Dividends

  • Abbott India Ltd Earnings Results

    Abbott India Ltd’s net profit jumped 24.04% since last year same period to ₹287.06Cr in the Q4 2023-2024. On a quarterly growth basis, Abbott India Ltd has generated -7.69% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Abbott India Ltd Dividends May,2024

    In the quarter ending March 2024, Abbott India Ltd has declared dividend of ₹410 - translating a dividend yield of 2.68%.

    Read More about Dividends

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Abbott India Ltd is currently in a Bearish trading position according to technical analysis indicators.

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Abbott India Ltd shares.

Abbott India Ltd (ABBOTINDIA) share price today is ₹27404.15

Abbott India Ltd is listed on NSE

Abbott India Ltd is listed on BSE

  • Today’s highest price of Abbott India Ltd is ₹28400.
  • Today’s lowest price of Abbott India Ltd is ₹27221.

Today’s traded volume of Abbott India Ltd(ABBOTINDIA) is 16.89K.

Today’s market capitalisation of Abbott India Ltd(ABBOTINDIA) is ₹61190.76Cr.

Abbott India Ltd(ABBOTINDIAPrice
52 Week High
₹29638.95
52 Week Low
₹22000

Abbott India Ltd(ABBOTINDIA) share price is ₹27404.15. It is down -7.54% from its 52 Week High price of ₹29638.95

Abbott India Ltd(ABBOTINDIA) share price is ₹27404.15. It is up 24.56% from its 52 Week Low price of ₹22000

Abbott India Ltd(ABBOTINDIAReturns
1 Day Returns
-1391.5%
1 Month Returns
1.85%
3 Month Returns
4.13%
1 Year Returns
15.8%